FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.
Csincsi, Ádám I; Szabó, Zsóka; Bánlaki, Zsófia; Uzonyi, Barbara; Cserhalmi, Marcell; Kárpáti, Éva; Tortajada, Agustín; Caesar, Joseph J E; Prohászka, Zoltán; Jokiranta, T Sakari; Lea, Susan M; Rodríguez de Córdoba, Santiago; Józsi, Mihály.
; 199(1): 292-303, 2017 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-28533443
Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.
An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
Crystallization of human complement component C3b in the presence of a staphylococcal complement-inhibitor protein (SCIN).
C-reactive protein and pentraxin-3 binding of factor H-like protein 1 differs from complement factor H: implications for retinal inflammation.
Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype.
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
Isolation of bovine complement factor H.
A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.
Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP.